EDIT vs NVST · rev $32.3M vs P/E 56, rev $2.51B
Editas Medicine Inc (EDIT) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported NVST revenue for 2024-12-31 was $2.51B. Net income was -$1.12B. Revenue was down 2.2% from 2023-12-31 to 2024-12-31. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
EDIT currently screens at market cap $375.2M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the EDIT and NVST stock pages for the full models.
Not investment advice.